Comparison of Genomic and Transcriptomic Patterns Between CTC and Metastatic Tumormetastatic Tumor

Circulating Tumor DNA Longitudinal Monitoring in Stage III-IV Lung Cancer Patients

NCT03664843 ·Status: UNKNOWN

The Value of Diagnosis and Outcome Prediction in CTC for Metastatic NPC Patients

NCT02505139 ·Status: COMPLETED

Feasibility of Mutational Analysis of Non-Small Cell Lung Cancer (NSCLC) Using Low-volume Lung Aspirates

NCT01482572 ·Status: WITHDRAWN

Multi-Omics Testing for Immunotherapy Efficacy Evaluation (MOTIVATION)

NCT04923802 ·Status: TERMINATED

Predictive Gene Profiles and Dynamic Measurement of Treatment Response in Metastatic Non-small Cell Lung Cancer

NCT03512847 ·Status: COMPLETED

The Establishment and Clinical Application of a Prediction Model of Lung Cancer Distant Metastasis Based on the Genomic Characteristics of Circulating Tumor Cells

NCT04568720 ·Status: UNKNOWN

A Comprehensive Evaluation of Circulating Tumor DNA and Circulating Tumor Cells as a Predictive Marker in Lung Cancer

NCT04254497 ·Status: COMPLETED

NGS-based Comprehensive Genomic ctDNA Panel in NSCLC With Immunotherapy

NCT04636047 ·Status: UNKNOWN

Study of Early-stage Lung Adenocarcinoma for Early Detection and Effective Treatment Strategy

NCT01482585 ·Status: UNKNOWN

Radiomic Assessment in NSCLC: Correlation Between Multiparametric Imaging Biomarkers and Genetic Biomarkers

NCT01585545 ·Status: ENROLLING_BY_INVITATION

Comparison of Gene Mutations in Matched Samples in Advanced Nonsquamous NSCLC Using NGS

NCT02416726 ·Status: COMPLETED ·Phase: NA

Cancer Panel From Blood of Lung Cancer Patients

NCT03235765 ·Status: UNKNOWN

MRD-guided Prognosis Prediction and Adjuvant Treatment Based on CTC and ctDNA in NSCLC

NCT06198868 ·Status: RECRUITING

Application of ctDNA in the Evaluation of Curative Effect and Prognosis of SCLC Patients

NCT05066945 ·Status: NOT_YET_RECRUITING

Assess Diversity of Gut Microbiome in Met NSCLC in Correlation to Tx & Adverse Effects

NCT06221800 ·Status: RECRUITING

Evaluating the Predictive Capability of Transcriptomic Profiling for Identifying the Primary Site of Metastatic Tumors

NCT07319949 ·Status: NOT_YET_RECRUITING

Comparison of Circulating Tumor DNA and Tumor Tissue DNA by Targeted Sequencing in Non-Small Cell Lung Cancer

NCT02645318 ·Status: COMPLETED

ctDNA Dynamic Monitoring and Its Role of Prognosis in Stage I NSCLS by NGS

NCT03172156 ·Status: COMPLETED

Cell Free DNA for the Diagnosis and Treatment in Early NSCLC

NCT03791034 ·Status: RECRUITING

The Utility of Circulating Tumor Cells as Confirmation of Pathologic Diagnosis in Patients With Suspected Early Stage Non-small Cell Lung Cancer

NCT02380196 ·Status: COMPLETED

The Detection of Circulating Tumor Cells (CTCs) in Patients With Lung Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment

NCT02412384 ·Status: COMPLETED

Multiple Omics Sequencing Technologies in Predicting the Efficacy and Monitoring the Recurrence of Non-Small Cell Lung Cancer

NCT07057102 ·Status: RECRUITING

A Study of Real-world Treatment Patterns and Outcomes in Chinese Advanced NSCLC Patients Who Previously Received at Least 2 Line Treatments

NCT06617390 ·Status: COMPLETED

A Study for Identification of Predictive Immune Biomarker for Atezolizumab Therapy in NSCLC Patients

NCT04312308 ·Status: COMPLETED

Liquid Biopsy in Advanced Oligometastatic NSCLC Receiving Surgery

NCT05648370 ·Status: UNKNOWN